Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 16, 2011

Platypus Licenses Cell Exclusion Zone Technology to Cell Biolabs

  • Platypus Technologies signed an agreement granting Cell Biolabs a license to use its cell exclusion zone technology. The deal allows Cell Biolabs to incorporate the technology into its CytoSelect™ cell-migration assays.

    “There is a growing demand for cell motility assays that allow visual assessment of cell morphology,” says Renee Herber, program manager at Platypus. “This partnership should allow us to service a greater number of researchers for whom more data per assay well is critical.”

    Cell Biolabs develops and commercializes assays and reagents to advance cell and molecular biology. Platypus’ Oris™ cell-based assay line is designed to aid life science researchers studying cell migration and cell invasion.

    Last October, the company launched the latest product in the Oris line, the Oris™ Pro 384 Cell Migration Assay. It is reportedly designed for high-throughput screening of chemical libraries for cancer therapeutics. The assay was developed using a $396,000 Innovative Molecular Analysis Technologies grant from the NCI.



Related content

Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »